sábado, 10 de enero de 2026

Responding to declining global fertility rates The Lancet +++ +...

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00034-6/fulltext?dgcid=raven_jbs_etoc_email Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01962-2/abstract?dgcid=raven_jbs_etoc_feature_lancet Tafasitamab, lenalidomide, and rituximab in relapsed or refractory follicular lymphoma (inMIND): a global, phase 3, randomised controlled trial https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)01778-7/abstract?dgcid=raven_jbs_etoc_feature_lancet Jan 10, 2026 Volume 407Number 10524p105-194 https://www.thelancet.com/journals/lancet/issue/vol407no10524/PIIS0140-6736(26)X0002-2

No hay comentarios:

Publicar un comentario